Related Experiment Video
Updated: Apr 24, 2026

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
Published on: June 2, 2021
Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4
Hye Sun Kuehn1, Weiming Ouyang2, Bernice Lo3,4
1Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA.
Abstract:
Cytotoxic T lymphocyte antigen-4 (CTLA-4) is an inhibitory receptor found on immune cells. The consequences of mutations in CTLA4 in humans are unknown. We identified germline heterozygous mutations in CTLA4 in subjects with severe immune dysregulation from four unrelated families. Whereas Ctla4 heterozygous mice have no obvious phenotype, human CTLA4 haploinsufficiency caused dysregulation of FoxP3(+) regulatory T (Treg) cells, hyperactivation of effector T cells, and lymphocytic infiltration of target organs. Patients also exhibited progressive loss of circulating B cells, associated with an increase of predominantly autoreactive CD21(lo) B cells and accumulation of B cells in nonlymphoid organs. Inherited human CTLA4 haploinsufficiency demonstrates a critical quantitative role for CTLA-4 in governing T and B lymphocyte homeostasis.
Insights
Mutations in Cytotoxic T lymphocyte antigen-4 (CTLA-4) cause severe immune dysregulation in humans, affecting T and B cell balance. This highlights CTLA-4
Area of Science:
- Immunology
- Genetics
Background:
- Cytotoxic T lymphocyte antigen-4 (CTLA-4) is an inhibitory receptor on immune cells.
- The effects of CTLA4 mutations in humans were previously unknown.
Purpose of the Study:
- To investigate the consequences of germline heterozygous mutations in CTLA4 in humans.
- To understand the role of CTLA-4 in immune system regulation and homeostasis.
Main Methods:
- Identified germline heterozygous mutations in CTLA4 in subjects with severe immune dysregulation.
- Compared human CTLA4 haploinsufficiency phenotype with heterozygous Ctla4 mice.
- Analyzed T regulatory (Treg) cell function, effector T cell activation, and B cell populations.
Main Results:
- Human CTLA4 haploinsufficiency led to FoxP3(+) regulatory T (Treg) cell dysregulation and effector T cell hyperactivation.
- Observed lymphocytic infiltration in target organs in patients.
- Documented progressive loss of circulating B cells, an increase in autoreactive CD21(lo) B cells, and B cell accumulation in nonlymphoid organs.
Conclusions:
- Inherited human CTLA4 haploinsufficiency reveals a critical quantitative role for CTLA-4 in maintaining T and B lymphocyte homeostasis.
- CTLA-4 is essential for preventing severe immune dysregulation in humans.

